New Therapeutic Targets in Tissue-Specific Manifestations of Type 2 Diabetes
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Endocrinology".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 30020
Special Issue Editors
Interests: type 2 diabetes mellitus; diabetic complications; cardiovascular disease; heart failure; chronic kidney disease
Special Issues, Collections and Topics in MDPI journals
Interests: internal medicine; hypertension; cardiovascular disease; clinical research
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Type 2 diabetes mellitus is a growing global pandemic, and projections concerning its prevalence are pessimistic. It is closely related to micro- and macrovascular complications, which augment overall morbidity and mortality, while also affecting patients’ quality of life. In addition to classic diabetic complications, type 2 diabetes mellitus is also interconnected with several other diseases, such as non-alcoholic fatty liver disease, dyslipidemia, and metabolic syndrome. There is increasing evidence regarding the tissue-specific manifestations of type 2 diabetes mellitus.
The aim of the present Special Issue is to highlight new research on tissue-specific manifestations of type 2 diabetes mellitus, from pathogenesis to treatment, along with narrative and systematic reviews summarizing relevant evidence published so far. We welcome original articles, narrative reviews, systematic reviews, and meta-analyses.
Dr. Dimitrios Patoulias
Dr. Michael Doumas
Dr. Christodoulos Papadopoulos
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- type 2 diabetes mellitus
- cardiovascular disease
- chronic kidney disease
- metabolic syndrome
- SGLT-2 inhibitors
- GLP-1 receptor agonists
- newer antidiabetics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.